Andrea Dennis-LaVigne

Board Member at Likarda

Andrea Dennis-LaVigne is a private practice veterinarian, founder, owner, and president of the Bloomfield Animal Hospital in Bloomfield, Connecticut. When she opened Bloomfield Animal Hospital she was the first African American veterinarian in Connecticut. Dr. Dennis-LaVigne has published articles in Veterinary Medicine and is the host of the radio show, Pet Talk, on WTIC 1080 and co-hosts the Better Pet segment on WFSB Television.

Professionally she has served as the President of the Connecticut Veterinary Medical Association Board (CVMA) as well as the Health Assistance Intervention Education Network (HAVEN) Board. A native of Hartford, her community service includes working with Habitat for Humanity, and for the past two decades, she has mentored hundreds of students in the Hartford county school systems.

Dr. Dennis-LaVigne is a dedicated alumnus of the University of Connecticut, honored with the Connecticut Alumni Service Award. She has served in various aspects of the University, including President of the Alumni Association, University President Search Committees 2007, 2010, and 2018, Foundation Board of Directors, President’s Athletic Advisory Committee, President’s Task Force on Diversity, and Chair of the Committee on Diversity and Opportunity. In 2013 she was appointed by the governor to the University of Connecticut Board of Trustees.

Dr. Dennis-LaVigne received a D.V.M. from Tuskegee University School of Veterinary medicine in 1982 and a bachelor’s degree from the University of Connecticut in 2003. After working on a Large Animal Residency at the University of California Davis, she was an associate professor at Ross University School of Veterinary Medicine, St. Kitts in the Caribbean. Andrea is an observer on the Likarda Board.

Location

Simsbury, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Likarda

1 followers

Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Their revolutionary method to coat cells with stealth hydrogels, called Core-Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body.


Employees

11-50

Links